Gradientech AB (publ) delårsrapport för Q1 2020 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Gradientech AB (publ) delårsrapport för Q1 2020 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Uppsala, April 30, 2020. Gradientech has closed a rights issue among its existing shareholders for a total of USD 2.1 million (SEK 21 million). The rights issue was oversubscribed with a subscription rate corresponding to 135 percent.
Gradientech AB (publ) announces today that the annual report for 2019 has been published and is available on the company’s website www.gradientech.se.
Gradientechs årsredovisning för 2019 har idag publicerats på bolagets hemsida.
Uppsala, March 27, 2020. Gradientech has been awarded with SEK 6.3M from the highly competitive BIO-X Accelerate program, to support the commercialization journey of its diagnostic system QuickMIC®. QuickMIC is an ultra-rapid system designed to provide fast and targeted treatment for sepsis patients.
Uppsala, February 26, 2020. Gradientech today announces the scientific publication of a navel multiplex fluidic chip for rapid antibiotic susceptibility testing (ASn. The chip can generate AST results within 2-4 ho urs, which is at least 20 hours faster than current AST methods used in hospital laboratories.
Gradientech AB (publ) year-end report for 2019 is now available in Swedish on the company’s website www.gradientech.se.
Gradientech AB:s (publ) bokslutskommuniké för 2019 finns nu tillgänglig på bolagets hemsida www.gradientech.se.
Uppsala, August 29, 2019. Gradientech AB today announces the trademark approval from the United States Patent and Trademark Office (USPTO) for QuickMIC®, its diagnostic system for ultrarapid antibiotic susceptibility testing. The registered trademark (Reg. No. 5817189) covers two classes for goods and services: Chemical and biological reagents for medical and veterinary use (IC 005) and diagnostic apparatus and instruments for analyzing cellular responses for medical and veterinary use (IC 010).
Uppsala, August 21, 2019. Gradientech AB, today announces that the company has received a Notice of Allowance from the United States Patent and Trademark Office for the patent application no. 14/903,032, “Use of a Fluidic Device”.